Overall DARE gets a technical rating of 0 out of 10. DARE's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
The long term trend is still negative, but the short term trend is neutral. It is advised to wait a little bit longer to see how this turns out.
When comparing the yearly performance of all stocks, DARE is a bad performer in the overall market: 86% of all stocks are doing better.
DARE is currently trading near the lower end of its 52 week range, which is not a good sign. The S&P500 Index is trading in the upper part of its 52 week range, so DARE is lagging the market.
In the last month DARE has a been trading in the 2.88 - 3.06 range, which is quite wide. It is currently trading near the lows of this range.
Warning: DARE has an average volume of 16565 traded shares per day. This is quite low and it might be dangerous to invest in illiquid stocks.
DARE is an average performer in the Pharmaceuticals industry, it outperforms 48% of 198 stocks in the same industry.